Neurocognitive Angle: The Search for Endophenotypes

Obsessive-Compulsive Disorder: Current Science and Clinical Practice

Volumn , Issue , 2012, Pages 300-326

  Chamberlain, Samuel R ^a   Menzies, Lara ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endophenotype strategy in OCD, its machinations with genes; Endophenotype, heritable risk factor, with epigenetic, pleiotropic role; Endophenotypes, and the overlap, OCD and related Axis I disorders; Endophenotyping, in multiple nonpsychiatric contexts; Hierarchical disease model, steps between genotype, phenotype; Neurocognitive angle, the search for endophenotypes; Neurocognitive tests on inhibitory control, and cognitive flexibility; OCD and brain neural circuitry, the 'neurocognitive angle'; OCD and confirming heritability, than just the familial; Translational medicine in cognitive, and neurotransmitter systems

Indexed keywords

EID: 84886510715     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119941125.ch12     Document Type: Chapter

References (104)

1. Stein DJ. Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry 2000;47:296-304.
2. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005;29:399-419.
3. Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:327-337.
4. Hollander E, Kwon JH, Stein DJ, Broatch J, Rowland CT, Himelein CA. Obsessivecompulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry 1996;57(Suppl. 8):3-6.
5. DuPont RL, Rice DP, Shiraki S, Rowland CR. Economic costs of obsessivecompulsive disorder. Med Interface 1995;8:102-109.
6. Rasmussen SA, Tsuang MT. The epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1984;45): 450-457.
7. Westenberg HG, Fineberg NA, Denys D. Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 2007;12(2 Suppl. 3):14-27.
8. Welch JM, Lu J, Rodriguiz RM et al . Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007;448:894-900.
9. Boulougouris V, Chamberlain SR, Robbins TW. Cross-species models of OCD spectrum disorders. Psychiatry Res 2009;170:15-21.
10. Fineberg NA, Potenza MN, Chamberlain SR et al . Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2010;35:591-604.
11. Aron AR, Robbins TW, Poldrack RA. Inhibition and the right inferior frontal cortex. Trends Cogn Sci 2004;8:170-177.
12. Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry 2007;20:255-261.
13. Kehagia AA, Murray GK, Robbins TW. Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 2010;20:199- 204.
14. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessivecompulsive disorder: a review. Twin Res Hum Genet 2005;8:450-458.
15. Pauls DL. The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med Genet C Semin Med Genet 2008;148:133-139.
16. Pauls DL, Alsobro ok JP 2nd, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.
17. Nestadt G, Samuels J, Riddle M et al . A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:358-363.
18. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-1578.
19. Carey G, Gottesman II. Twin and family studies of anxiety, phobic and obsessive disorders. In: Klein D, Radkin J (eds), Anxiety; NewResearch and Changing Concepts. New York: Raven Press, 1981, pp. 117-136.
20. Hudziak JJ, Van Beijsterveldt CE, Althoff RR et al . Genetic and environmental contributions to the Child Behavior Checklist Obsessive-Compulsive Scale: a crosscultural twin study. Arch Gen Psychiatry 2004;61:608-616.
21. Hanna GL, Veenstra-VanderWeele J, Cox NJ et al . Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 2002;114:541-552.
22. Willour VL, Yao Shugart Y, Samuels J et al . Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet 2004;75:508- 513.
23. Dickel DE, Veenstra-VanderWeele J, CoxNJ et al . Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 2006;63:778-785.
24. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006;63:769-776.
25. Shugart YY, Wang Y, Samuels JF et al . A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet 2009;150B:886-892.
26. Shugart YY, Samuels J, Willour VL et al . Genomewide linkage scan for obsessivecompulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 2006;11:763-770.
27. Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci 2010;12:149-163.
28. Hasler G, Drevets WC, Gould TD, Gottesman, II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006;60:93-105.
29. Gould TD, Gottesman II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 2006;5:113-119.
30. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645.
31. Insel TR, Collins FS. Psychiatry in the genomics era. Am J Psychiatry 2003;160:616-620.
32. Chamberlain SR, Menzies L. Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential. Expert Rev Neurother 2009;9:1133-1146.
33. Oh G, Petronis A. Environmental studies of schizophrenia through the prism of epigenetics. Schizophr Bull 2008;34:1122-1129.
34. Roy N, Kahlem P, Dausse E et al . Exclusion of HRAS from long QT locus. Nat Genet 1994;8:113-114.
35. Wang Q, Curran ME, Splawski I et al . Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23.
36. Aukes MF, Alizadeh BZ, Sitskoorn MM, Kemner C, Ophoff RA, Kahn RS. Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia. Biol Psychiatry 2009;65:527-534.
37. Freedman R, Adler LE, Baker N, Waldo M, Mizner G. Candidate for inherited neurobiological dysfunction in schizophrenia. Somat Cell Mol Genet 1987;13:479-484.
38. Siegel C, Waldo M, Mizner G, Adler LE, Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatry 1984;41:607-612.
39. Freedman R, Coon H, Myles-Worsley M et al . Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 1997;94:587-592.
40. Leonard S, Adams C, Breese CR et al . Nicotinic receptor function in schizophrenia. Schizophr Bull 1996;22:431-445.
41. Leonard S, Gault J, Hopkins J et al . Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002;59:1085-1096.
42. Leiser SC, Bowlby MR, Comery TA, Dunlop J. A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther 2009;122:302-311.
43. Olincy A, Braff DL, Adler LE et al . Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res 2010;119:175-182.
44. Tregellas JR, Olincy A, Johnson L et al . Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. Neuropsychopharmacology 2010;35:938-942.
45. Hollander E, Kim S, Khanna S, Pallanti S. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr 2007;12(2 Suppl. 3):5-13.
46. Drachman DA. Do we have brain to spare? Neurology 2005;64:2004-2005.
47. Thompson PM, Cannon TD, Narr KL et al . Genetic influences on brain structure. Nat Neurosci 2001;4:1253-1258.
48. Wright IC, Sham P, Murray RM, Weinberger DR, Bullmore ET. Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage 2002;17:256-271.
49. Toga AW, Thompson PM. Genetics of brain structure and intelligence. Annu Rev Neurosci 2005;28:1-23.
50. Greisberg S, McKay D. Neuropsychology of obsessive-compulsive disorder: a review and treatment implications. Clin Psychol Rev 2003;23:95-117.
51. Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry 2006;163:1282-1284.
52. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 1984;10:276-291.
53. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 2003;6:115-116.
54. Rubia K, Smith AB, Brammer MJ, Taylor E. Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. Neuroimage 2003;20:351-358.
55. Hampshire A, Chamberlain SR, Monti MM, Duncan J, Owen AM. The role of the right inferior frontal gyrus: inhibition and attentional control. Neuroimage 2010;50:1313-1319.
56. Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology (Berl) 2009;205:273-283.
57. Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 2009;32:267-287.
58. Chamberlain SR, Hampshire A, M̈uller U et al . Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 2009;65:550-555.
59. Robinson ES, Eagle DM, Mar AC et al . Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008;33:1028-1037.
60. Chamberlain SR, Del Campo N, Dowson J et al . Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 2007;62:977-984.
61. Chamberlain SR, M̈uller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 2006;311:861-863.
62. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1991;29:993-1006.
63. Hampshire A, Owen AM. Fractionating attentional control using event-related fMRI. Cereb Cortex 2006;16:1679-1689.
64. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987;44:211-218.
65. Swedo SE, Schapiro MB, Grady CL et al . Cerebral glucose metabolism in childhoodonset obsessive-compulsive disorder. Arch Gen Psychiatry 1989;46:518-523.
66. Baxter LR Jr, Schwartz JM, Mazziotta JC et al . Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988;145:1560-1563.
67. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 1989;2:23-28.
68. McGuire PK, Bench CJ, Frith CD, Marks IM, Frackowiak RS, Dolan RJ. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994;164:459-468.
69. Rauch SL, Jenike MA, Alpert NM et al . Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994;51:62-70.
70. Cottraux J, Gerard D, Cinotti L et al . A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res 1996;60:101-112.
71. Perani D, Colombo C, Bressi S et al . [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry 1995;166:244-250.
72. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357- 381.
73. Szeszko PR, Robinson D, Alvir JM et al . Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56:913- 919.
74. Choi JS, Kang DH, Kim JJ et al . Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive-compulsive disorder. J Psychiatr Res 2004;38:193-199.
75. Kang DH, Kim JJ, Choi JS et al . Volumetric investigation of the frontal-subcortical circuitry in patients with obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 2004;16:342-349.
76. Atmaca M, Yildirim BH, Ozdemir BH, Aydin BA, Tezcan AE, Ozler AS. Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1051-1057.
77. Atmaca M, Yildirim H, Ozdemir H, Tezcan E, Poyraz AK. Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:46-52.
78. Robinson D, Wu H, Munne RA et al . Reduced caudate nucleus volume in obsessivecompulsive disorder. Arch Gen Psychiatry 1995;52:393-398.
79. Rosenberg DR, Keshavan MS, O'Hearn KM et al . Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 1997;54:824-830.
80. Szeszko PR, MacMillan S, McMeniman M et al . Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 2004;161:1049-1056.
81. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessivecompulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008;32:525-549.
82. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 1999;18:32-42.
83. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.
84. Rotge JY, Langbour N, GuehlD et al . Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis. Neuropsychopharmacology 2010;35:686-691.
85. Harrison BJ, Yucel M, Shaw M et al . Evaluating brain activity in obsessivecompulsive disorder: preliminary insights from a multivariate analysis. Psychiatry Res 2006;147:227-231.
86. Soriano-Mas C, Pujol J, Alonso P et al . Identifying patients with obsessive-compulsive disorder using whole-brain anatomy. Neuroimage 2007;35:1028-1037.
87. McIntosh AR, Lobaugh NJ. Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage 2004;23(Suppl. 1):S250-263.
88. Odlaug BL, Chamberlain SR, Grant JE. Motor inhibition and cognitive flexibility in pathologic skin picking. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:208-211.
89. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of OCD patients: on the trail of endophenotypes. Am J Psychiatry 2007;164:335- 338.
90. Delorme R, Gousse V, Roy I et al . Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder. Eur Psychiatry 2007;22:32-38.
91. Viswanath B, Janardhan Reddy YC, Kumar KJ, Kandavel T, Chandrashekar CR. Cognitive endophenotypes in OCD: a study of unaffected siblings of probands with familial OCD. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:610-615.
92. Cavedini P, Zorzi C, Piccinni M, Cavallini MC, Bellodi L. Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. Biol Psychiatry 2010;67:1178-1184.
93. Menzies L, Achard S, Chamberlain SR et al . Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007;130:3223-3236.
94. Menzies L, Williams GB, Chamberlain SR et al . White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry 2008;165:1308-1315.
95. Le Bihan D, Mangin JF, Poupon C et al . Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534-546.
96. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209-219.
97. Beaulieu C. The basis of anisotropicwater diffusion in the nervous system - a technical review. NMR Biomed 2002;15:435-455.
98. Chamberlain SR, Menzies L, Hampshire A et al . Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008;321:421-422.
99. Fineberg NA, Sharma P, Sivakumaran T, Sahakian B, Chamberlain SR. Does obsessive-compulsive personality disorder belong within the obsessive-compulsive spectrum? CNS Spectr 2007;12:467-482.
100. Rector NA, Cassin SE, Richter MA, Burroughs E. Obsessive beliefs in first-degree relatives of patients with OCD: a test of the cognitive vulnerability model. J Anxiety Disord 2009;23:145-149.
101. Hur YM. Genetic and environmental covariations among obsessive-compulsive symptoms, neuroticism, and extraversion in South Korean adolescent and young adult twins. Twin Res Hum Genet 2009;12:142-148.
102. Beatty J, Laughlin RE. Genomic regulation of natural variation in cortical and noncortical brain volume. BMC Neurosci 2006;7:16.
103. Greenwood TA, Braff DL, Light GA et al . Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 2007;64:1242-1250.
104. Dick DM, Jones K, Saccone N et al . Endophenotypes successfully lead to gene identification: results from the collaborative study on the genetics of alcoholism. Behav Genet 2006;36:112-126.